PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q1 2022 Results - Earnings Call Transcript [Seeking Alpha]
PDS Biotechnology Corporation (PDSB)
Last pds biotechnology corporation earnings: 11/7 06:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
PDS Biotechnology Corporation. (NASDAQ:PDSBCompany ParticipantsGabrielle DeGravina - Investor Relations, CG CapitalFrank Bedu-Addo - Chief Executive OfficerLauren Wood - Chief Medical OfficerMatthew Hill - Chief Financial OfficerConference Call ParticipantsLouise Chen - Cantor FitzgeraldLeland Gershell - OppenheimerLaura Suriel - Alliance Global PartnersRobert LeBoyer - Noble CapitalOperatorHello and welcome to PDS Biotechnology First Quarter 2022 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.It's now my pleasure to turn the call over to Gabby DeGravina. Please go ahead.Good morning. And welcome to PDS Biotechnology's first quarter 2022 earnings conference call and audio webcast. With me today from the company are Dr. Frank Bedu-Addo, Chief Executive Officer, Dr. Lauren B. Wood, Chief Medical Officer, and Ma
Show less
Read more
Impact Snapshot
Event Time:
PDSB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PDSB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PDSB alerts
High impacting PDS Biotechnology Corporation news events
Weekly update
A roundup of the hottest topics
PDSB
News
- PDS Biotechnology Corporation's (NASDAQ:PDSB) market cap dropped US$1.5m last week; individual investors who hold 59% were hit as were institutions [Yahoo! Finance]Yahoo! Finance
- PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- PDS Biotechnology Co. (NASDAQ: PDSB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.MarketBeat
- PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial ResultsGlobeNewswire
PDSB
Earnings
- 11/14/23 - Beat
PDSB
Analyst Actions
- 3/27/24 - HC Wainwright
PDSB
Sec Filings
- 3/28/24 - Form S-8
- 3/28/24 - Form 10-K
- 3/27/24 - Form 8-K
- PDSB's page on the SEC website